We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Xenon System Protects the Brain in Critically ill Newborns

By HospiMedica International staff writers
Posted on 21 Aug 2009
A newly developed closed circuit xenon (Xe) breathing system may make xenon safe and cost-efficient for use in protecting the brains of critically ill infants, according to a new study.

Developed by researchers at the University of Wales (Swansea, United Kingdom) and the University of Bristol (United Kingdom), the closed circuit Xe delivery system is fitted to a conventional newborn ventilator, and essentially recaptures the exhaled xenon so that the infant can rebreathe it. More...
The system also replenishes precise amounts of oxygen and other gases as needed. Functionally, the neonatal ventilator provided breaths of oxygen to a lower chamber, compressing a hanging bag within it; this bag communicated with the upper closed part of the breathing system that contains soda lime, unidirectional valves, Xe-oxygen analyzers, and a tracheal tube connection. At each end-inspiration, this bag emptied fully and a bolus of oxygen (the driving gas) crosses over from the lower to upper chamber via an additional valve. This mechanically substitutes the gas uptake from the circle during the previous breath cycle (i.e., oxygen + small volume of Xe) with an equivalent volume of oxygen, creating a slow-rising inspired oxygen concentration. This is offset by manual injection of Xe boluses, infrequently at steady state, due to the low-Xe uptake of the patient.

The system takes advantage of the fact that uptake of xenon by the lung is very low: when a given amount of xenon is inhaled, most of it is then exhaled out again. The Xe delivery method was tested successfully in newborn pigs for up to 16 hours, and the researchers found that they could precisely control the depth of anesthesia, while delivering exactly the right amount of oxygen. The piglets had stable vital signs and recovered without any complications. Using the closed circuit system, the researchers estimate that xenon could be used for surgery in critically ill newborns for as little as U.S. $2 per hour, and the system itself could be developed as a single use device, with or without cooling of body temperature (hypothermia), previously the only technique known to protect the brain in infants with low-oxygen injury. The study was published in the August 2009 issue of Anesthesia & Analgesia.

"We believe that the simple design and operational cost of the system should make the delivery of xenon—once considered prohibitively expensive for routine medical use—safe and inexpensive for newborns requiring surgery and anesthesia for life-threatening birth defects,” concluded lead author John Dingley, M.D., of the University of Wales, and colleagues.

Xenon is a colorless, heavy, odorless noble gas, present in the Earth's atmosphere in trace amounts. Xenon has profound biological effects; in high concentrations, it can induce unconsciousness. For several years, researchers have known that xenon provides protection against some forms of low-oxygen injury to the brain. However, because xenon is very expensive, its use is currently limited to a few experimental centers.

Related Links:

University of Wales
University of Bristol



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.